U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

1947
100
Substance Class Protein
Created
by admin
on Mon Mar 31 20:45:50 GMT 2025
Edited
by admin
on Mon Mar 31 20:45:50 GMT 2025
Protein Sub Type
Sequence Type COMPLETE
Record UNII
N94833051K
Record Status Validated (UNII)
Record Version
  • Download
Related Record Type
Name Type Language
HUMAN FIBRINOGEN
EMA EPAR   EP  
Preferred Name English
FIBRINOGEN HUMAN
Common Name English
FIBRINOGEN HUMAN PLASMA-DERIVED
Common Name English
FIBRINOGEN [MI]
Common Name English
HUMAN FIBRINOGEN [EP MONOGRAPH]
Common Name English
FIBRINOGEN (HUMAN)
Common Name English
RAPLIXA
Brand Name English
Haemocomplettan P
Brand Name English
Factor i (fibrinogen) [WHO-DD]
Common Name English
FIBRINOGEN [VANDF]
Common Name English
FACTOR I (FIBRINOGEN)
WHO-DD  
Common Name English
FIBRINOGEN [MART.]
Common Name English
PARENOGEN
Brand Name English
HUMAN FIBRINOGEN [EP IMPURITY]
Common Name English
HUMAN FIBRINOGEN [EMA EPAR]
Common Name English
EVARREST
Brand Name English
ARTISS COMPONENT FIBRINOGEN HUMAN
Brand Name English
FACTOR I HUMAN
Common Name English
Classification Tree Code System Code
EMA ASSESSMENT REPORTS EVARREST (AUTHORIZED: HEMOSTASIS)
Created by admin on Mon Mar 31 20:45:50 GMT 2025 , Edited by admin on Mon Mar 31 20:45:50 GMT 2025
EMA ASSESSMENT REPORTS TACHOSIL (AUTHORIZED: HEMOSTASIS, SURGICAL)
Created by admin on Mon Mar 31 20:45:50 GMT 2025 , Edited by admin on Mon Mar 31 20:45:50 GMT 2025
WHO-VATC QB02BB01
Created by admin on Mon Mar 31 20:45:50 GMT 2025 , Edited by admin on Mon Mar 31 20:45:50 GMT 2025
NDF-RT N0000184169
Created by admin on Mon Mar 31 20:45:50 GMT 2025 , Edited by admin on Mon Mar 31 20:45:50 GMT 2025
FDA ORPHAN DRUG 245107
Created by admin on Mon Mar 31 20:45:50 GMT 2025 , Edited by admin on Mon Mar 31 20:45:50 GMT 2025
WHO-ATC B02BB01
Created by admin on Mon Mar 31 20:45:50 GMT 2025 , Edited by admin on Mon Mar 31 20:45:50 GMT 2025
FDA ORPHAN DRUG 88595
Created by admin on Mon Mar 31 20:45:50 GMT 2025 , Edited by admin on Mon Mar 31 20:45:50 GMT 2025
NCI_THESAURUS C78311
Created by admin on Mon Mar 31 20:45:50 GMT 2025 , Edited by admin on Mon Mar 31 20:45:50 GMT 2025
EMA ASSESSMENT REPORTS RAPLIXA (AUTHORIZED: HEMOSTASIS, SURGICAL)
Created by admin on Mon Mar 31 20:45:50 GMT 2025 , Edited by admin on Mon Mar 31 20:45:50 GMT 2025
EMA ASSESSMENT REPORTS EVICEL (AUTHORIZED: HEMOSTASIS, SURGICAL)
Created by admin on Mon Mar 31 20:45:50 GMT 2025 , Edited by admin on Mon Mar 31 20:45:50 GMT 2025
Code System Code Type Description
MERCK INDEX
m5370
Created by admin on Mon Mar 31 20:45:50 GMT 2025 , Edited by admin on Mon Mar 31 20:45:50 GMT 2025
PRIMARY Merck Index
DAILYMED
N94833051K
Created by admin on Mon Mar 31 20:45:50 GMT 2025 , Edited by admin on Mon Mar 31 20:45:50 GMT 2025
PRIMARY
UNIPROT
P02671
Created by admin on Mon Mar 31 20:45:50 GMT 2025 , Edited by admin on Mon Mar 31 20:45:50 GMT 2025
PRIMARY
ECHA (EC/EINECS)
232-598-6
Created by admin on Mon Mar 31 20:45:50 GMT 2025 , Edited by admin on Mon Mar 31 20:45:50 GMT 2025
PRIMARY
FDA UNII
N94833051K
Created by admin on Mon Mar 31 20:45:50 GMT 2025 , Edited by admin on Mon Mar 31 20:45:50 GMT 2025
PRIMARY
UNIPROT
P02679
Created by admin on Mon Mar 31 20:45:50 GMT 2025 , Edited by admin on Mon Mar 31 20:45:50 GMT 2025
PRIMARY
RXCUI
2264108
Created by admin on Mon Mar 31 20:45:50 GMT 2025 , Edited by admin on Mon Mar 31 20:45:50 GMT 2025
PRIMARY
DRUG BANK
DB09222
Created by admin on Mon Mar 31 20:45:50 GMT 2025 , Edited by admin on Mon Mar 31 20:45:50 GMT 2025
PRIMARY
MESH
D005340
Created by admin on Mon Mar 31 20:45:50 GMT 2025 , Edited by admin on Mon Mar 31 20:45:50 GMT 2025
PRIMARY
NDF-RT
N0000175979
Created by admin on Mon Mar 31 20:45:50 GMT 2025 , Edited by admin on Mon Mar 31 20:45:50 GMT 2025
PRIMARY Increased Coagulation Activity [PE]
SMS_ID
100000090630
Created by admin on Mon Mar 31 20:45:50 GMT 2025 , Edited by admin on Mon Mar 31 20:45:50 GMT 2025
PRIMARY
UNIPROT
P02675
Created by admin on Mon Mar 31 20:45:50 GMT 2025 , Edited by admin on Mon Mar 31 20:45:50 GMT 2025
PRIMARY
CAS
9001-32-5
Created by admin on Mon Mar 31 20:45:50 GMT 2025 , Edited by admin on Mon Mar 31 20:45:50 GMT 2025
PRIMARY
NCI_THESAURUS
C81126
Created by admin on Mon Mar 31 20:45:50 GMT 2025 , Edited by admin on Mon Mar 31 20:45:50 GMT 2025
PRIMARY
NDF-RT
N0000007914
Created by admin on Mon Mar 31 20:45:50 GMT 2025 , Edited by admin on Mon Mar 31 20:45:50 GMT 2025
PRIMARY Blood Coagulation Factors [Chemical/Ingredient]
EVMPD
SUB12502MIG
Created by admin on Mon Mar 31 20:45:50 GMT 2025 , Edited by admin on Mon Mar 31 20:45:50 GMT 2025
PRIMARY
ChEMBL
CHEMBL2109072
Created by admin on Mon Mar 31 20:45:50 GMT 2025 , Edited by admin on Mon Mar 31 20:45:50 GMT 2025
PRIMARY
From To
3_326 3_339
3_153 3_182
2_394 2_407
2_197 3_135
2_201 2_286
2_80 3_19
1_442 1_472
1_165 2_193
1_161 3_139
1_49 2_76
1_45 3_23
1_36 2_65
Glycosylation Type HUMAN
Glycosylation Link Type Site
N 1_400
N 1_667
N 1_812
N 2_364
N 3_52
O 1_285
O 1_316
Related Record Type Details
FIBRINOGEN
SUB_CONCEPT->SUBSTANCE
FIBRINOGEN CONCENTRATE (HUMAN)
SUB_CONCEPT->SUBSTANCE
THROMBIN ALFA
ENZYME->SUBSTRATE
ACUTOBIN
SUBSTRATE -> TARGET
Thrombin-like snake venom serine protease that coagulates human fibrinogen by hydrolysis of the alpha chains (FGA).
Related Record Type Details
FIBRINOGEN HUMAN
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
Molecular Formula CHEMICAL
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966